Results 211 to 220 of about 42,414 (275)

Detection of vaccine-derived poliovirus type 2 from sewage samples and public health response, Poland, November to December 2024. [PDF]

Euro Surveill
Wieczorek M, Gad B, Krzysztoszek A, Kłosiewicz P, Oleksiak K, Zaborski B, Grzesiowski P, Tkaczuk K, Baumann-Popczyk A.   +8 more
europepmc   +1 more source

The emergence of the circulating vaccine-derived poliovirus type 2 in multiple countries requires active surveillance: current scenario and counteracting strategies. [PDF]

Int J Surg
Mohapatra RK, Kutikuppala LVS, Seidel V, Ansari A, Mishra S, Mishra S, Kandi V.   +6 more
europepmc   +1 more source

Gut microbiota as a regulator of vaccine efficacy: implications for personalized vaccination. [PDF]

Gut Microbes
Lu Q, Feng Y, Wang H, Zhu K, Teng L, Yue M, Li Y.   +6 more
europepmc   +1 more source

Non-detection of emerging and re-emerging pathogens in wastewater surveillance to confirm absence of transmission risk: A case study of polio in New York. [PDF]

PLOS Glob Public Health
Larsen DA, Hill D, Zhu Y, Alazawi M, Chatila D, Dunham C, Faruolo C, Ferro B, Godinez A, Hanson B, Insaf T, Lang D, Neigel D, Neyra M, Pulido N, Wilder M, Yang N, Kmush B, Green H.   +18 more
europepmc   +1 more source

Securing the Future: Strategies for Global Polio Vaccine Security Amid Eradication Efforts. [PDF]

Vaccines (Basel)
Harutyunyan V, Ottosen A, Burke RM, Ehrhardt D, Shirey M, Durham R, Woods D.   +6 more
europepmc   +1 more source

Impact of novel Oral Poliovirus Type 2 vaccination campaigns: A seroprevalence survey in Nigeria, 2022.

Vaccine
Iliyasu Z, Danzomo AA, Jeyaseelan V, Gofama MM, Akintan PE, Akinrinoye OO, Also U, Abdullahi H, Mawashi KY, Gajida AU, Sifontes G, Mainou BA, Cavestany RL, Mach O, Verma H.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Vaccination with Inactivated Poliovirus Vaccine and Oral Poliovirus Vaccine in Denmark

Clinical Infectious Diseases, 1984
In Denmark a polio vaccination program including both inactivated poliovirus vaccine (IPV) and oral poliovirus vaccine ( OPV ) has been in use since 1968. Three injections of IPV are given when the children are five, six, and 15 months of age. Subsequently, three vaccinations with trivalent OPV are administered at the age of three, four, and five years.
Inger Petersen, Herdis von Magnus
openaire   +3 more sources